- Home
- PHVS vs SSTK Comparison
PHVS vs SSTK Comparison
Compare PHVS & SSTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHVS
- SSTK
- Stock Information
- Founded
- PHVS 2015
- SSTK 2003
- Country
- PHVS Netherlands
- SSTK United States
- Employees
- PHVS N/A
- SSTK N/A
- Industry
- PHVS Biotechnology: Pharmaceutical Preparations
- SSTK EDP Services
- Sector
- PHVS Health Care
- SSTK Technology
- Exchange
- PHVS Nasdaq
- SSTK Nasdaq
- Market Cap
- PHVS 1.0B
- SSTK 1.1B
- IPO Year
- PHVS 2021
- SSTK 2012
- Fundamental
- Price
- PHVS $17.11
- SSTK $29.47
- Analyst Decision
- PHVS Strong Buy
- SSTK Buy
- Analyst Count
- PHVS 5
- SSTK 4
- Target Price
- PHVS $41.60
- SSTK $50.33
- AVG Volume (30 Days)
- PHVS 49.2K
- SSTK 1.0M
- Earning Date
- PHVS 11-13-2024
- SSTK 02-25-2025
- Dividend Yield
- PHVS N/A
- SSTK 4.49%
- EPS Growth
- PHVS N/A
- SSTK N/A
- EPS
- PHVS N/A
- SSTK 1.01
- Revenue
- PHVS N/A
- SSTK $902,175,000.00
- Revenue This Year
- PHVS N/A
- SSTK $9.28
- Revenue Next Year
- PHVS N/A
- SSTK $12.47
- P/E Ratio
- PHVS N/A
- SSTK $29.13
- Revenue Growth
- PHVS N/A
- SSTK 3.09
- 52 Week Low
- PHVS $15.21
- SSTK $27.30
- 52 Week High
- PHVS $33.00
- SSTK $54.41
- Technical
- Relative Strength Index (RSI)
- PHVS 38.75
- SSTK 46.18
- Support Level
- PHVS $17.11
- SSTK $28.45
- Resistance Level
- PHVS $18.70
- SSTK $29.84
- Average True Range (ATR)
- PHVS 1.10
- SSTK 1.39
- MACD
- PHVS -0.07
- SSTK -0.09
- Stochastic Oscillator
- PHVS 34.65
- SSTK 42.45
About PHVS Pharvaris N.V.
Pharvaris NV is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to prevent and treat HAE attacks. By directly pursuing this clinically therapeutic target with novel small molecules, With positive data in both Phase 2 prophylaxis and studies in HAE, Pharvaris is developing deucrictibant. Pharvaris is currently enrolling a pivotal Phase 3 study for the treatment of HAE attacks and plans to initiate a pivotal Phase 3 study of deucrictibant for the prevention of HAE attacks.
About SSTK Shutterstock Inc.
Shutterstock Inc is a U.S.-based company that is engaged in the provision of digital content. The content segment, whose offerings include licenses for Images, Footage, Music, 3 Dimensional, and Generative AI content. Data, Distribution, and Service offerings address customer demand for products and services that are beyond its Content licenses. The company generates the majority of its revenue from Content offerings. Geographically the company generates the majority of its revenue from the Domestic market.